Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Global CNS Drug Market: Strategic Assessments of Leading SuppliersVenture Planning Group (www.VPGMarketResearch.com) is pleased to announce completion of a new market research and technology assessment report, "Global CNS Drug Market: Strategic Assessments of Leading Suppliers."
This report provides industry executives with strategically significant competitor information and analysis of the leading players in the CNS Drug Market. This report provides a worldwide strategic overview of the pharmaceutical market, including: •Sales forecast for major product segments: ethical, OTC, generics. •Sales forecast for major drug categories. •Sales forecasts by geographical region: North America, Europe, Japan, Latin America. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth. The report’s major objectives include: •To establish a comprehensive, factual, annually updated and cost-effective information based on performance, capabilities, goals and strategies of the leading players in the CNS drug market. •To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis the leading competitors. •To assist potential market entrants in evaluating prospective acquisition and joint venture candidates. •To complement organizations’ Contains 1,353 pages and 127 tables To review or order this report, please visit http://www.vpgmarketresearch.com/ To review related reports, please visit http://www.VPGMarketResearch.com Contact Robert Fisher robert@vpgcorp.com +1 212 564 2838 # # # Venture Planning Group is an international market research, publishing and management consulting firm, providing syndicated and custom services to corporate executives and key decision-makers in the Diagnostics, Pharmaceutical, Imaging, Orthopedics, Biotechnology, Chemical, Flavors & Fragrances, Food & Beverage, Electronics, and other industries. During numerous proprietary single-client consulting assignments and over 500 multiclient studies, VPG has developed an extensive database on various industries, technologies, markets, companies, products, and executives worldwide. VPG has served over 1,000 corporations in 70 countries, and has established a broad network of worldwide contacts with industry executives, opinion leaders, and experts from leading universities, research centers, the financial community and the government. Specialties Market Intelligence Surveys, Opportunity Analyses, New Technology/Product Assessments, Acquisition/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|